Navigation Links
Inverness Medical Innovations Announces Second Quarter 2008 Results
Date:7/29/2008

$(1.17) $0.25

Diluted $(1.17) (i) $0.24 (k)

Weighted average common shares -

basic 46,671 46,671

Weighted average common shares -

diluted 46,671 (i) 48,512 (k)

(a) In calculating net income or loss on an adjusted cash basis, the

Company excludes from net income or loss (i) certain non-cash charges,

including amortization expense and stock-based compensation expense, (ii)

non-recurring charges and income, and (iii) certain other charges and

income that have a significant positive or negative impact on results yet

do not occur on a consistent or regular basis in its business. In

determining whether a particular item meets one of these criteria,

management considers facts and circumstances that it believes are

relevant. Management believes that excluding such charges and income from

income or loss allows investors and management to evaluate and compare the

Company's operating results from continuing operations from period to

period in a meaningful and consistent manner. Due to the frequency of

their occurrence in its business, the Company does not adjust net income

or loss for the costs associated with litigation, including payments made

or received through settlements. It should be noted that "net income or

loss on an adjusted cash basis" is not a standard financial measurement

under accounting principles generally accepted in the United States of

America ("GAAP") and should not be considered as an alternative to net

income or loss or cash flow from operating activities, as a measure of

liquidity or as an indicator of operating performance or any measure of

performance derived in accordance with GAAP.

(b) Amortizati
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Agrees to Acquire Panbio Ltd.
2. Inverness - Chemogen Establish Exclusive License for TB Antibodies
3. Inverness Medical Innovations Announces Proposed Public Offering of Common Stock
4. Inverness Medical Innovations Agrees to Acquire ParadigmHealth
5. Inverness Medical Innovations Acquires ParadigmHealth
6. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 2008
7. Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
8. Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
9. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
10. Inverness Medical Innovations Announces Fourth Quarter 2007 Results
11. Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Del. and CHARLOTTESVILLE, Va., Dec. 15 /PRNewswire-FirstCall/ ... and the University of Virginia (UVa) in ... into a strategic research collaboration to enhance ... artery disease (CAD) with a secondary focus ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative ...
(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...
(Date:12/15/2009)... Prinz Law Office has announced the launch of several ... secure legal services in the current economic climate. ... the opportunity to finance legal services over a period ... any equity in their start-up companies. The second ... fixed montly payment arrangements over 6 to 12 month ...
(Date:12/14/2009)... Patrick Kennedy Joins with State Biotech Leaders ... in Research and Development while Boosting Rhode ... ,, PROVIDENCE, R.I., Dec. 14 /PRNewswire-USNewswire/ ... leaders in research, medicine and biotechnology gathered ... to discuss the importance of medical innovation ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... time and effort needed for,transformationswithout compromise! , Anna ... Alan Greener ,Stratagene , Stratagene introduces competent cells ... an easy-to-use, single-reaction format that,yield the supercompetent efficiency of ... or the competent efficiency of 1 x 10 ...
... and one-step purification from a more versatile vector ... FLAG ,Epitope Tagging in E. coli , ... Peter,Vaillancourt ,Stratagene , Stratagene has improved the ... new pCAL-n-FLAG vector. This new E. coli cloning ...
... and report data with the MutaTrak electronic notebook ... , Marc Hamovitch Doug Schroeder ,Solana Consulting Group, ... notebook to record Big,Blue ... Data are entered in a logical order and updated ...
Other Biology Technology:XL10-Gold Cells Supplied in New Single-Reaction Format 2XL10-Gold Cells Supplied in New Single-Reaction Format 3XL10-Gold Cells Supplied in New Single-Reaction Format 4High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 2High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 3High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 4High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 5High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 6High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 7High-Level Protein Expression, One-Column Purification, and FLAG,Epitope Tagging in E. coli 8Organize Your Data from the Big Blue Mutation Assay 2Organize Your Data from the Big Blue Mutation Assay 3
(Date:12/16/2009)... rituals can help them get psyched up for contests, ... which many athletes gobble down before and during events, ... "These agents are treatments for the symptoms of an ... research at Indiana University focuses on musculoskeletal health and ... or train at a certain level, but pain occurs ...
(Date:12/16/2009)... 1 iQor, a global provider of business ... InfoWorld 100 Awards Top 100 IT project ... was the first submission for iQor. ,, "We are ... companies," said Vikas Kapoor, president and CEO of iQor. ... allowing us to work faster, smarter and with the ...
(Date:12/16/2009)... IgeaCare Solutions Inc. is pleased to ... healthcare communications company previously operating as IgeaCare Systems ... move forward under new leadership and funding. ,, ... to the position of Chief Executive Officer. Under ... providing a superior servicing and support model; fast ...
Breaking Biology News(10 mins):NSAIDs: Take 'em early and often when competing? Think again 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2New IVF Software MedITEX to be Presented at the ESHRE Exhibition 12663 1New IVF Software MedITEX to be Presented at the ESHRE Exhibition 12663 2Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 1Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 2Oclaro 28TM 29 Hits Milestone With Clarity 28TM 29 Fluorescence Filters 12662 3Inoperable Colon Cancer Responds to New Treatment 49145 1Inoperable Colon Cancer Responds to New Treatment 49145 2
... 15, 2008) Infants and adults with the blood cancer ... infants die before their first birthdays. Although there are varying ... of two genes, the MLL and the AF4 genes. ... the AF4 gene, a potent cancer-causing oncogene is created. Although ...
... The next person who reminds you to floss might be ... some time that a protein associated with inflammation (called CRP) ... disease. But where,s the inflammation coming from? A new research ... The FASEB Journal shows that infected gums may be ...
... cell lines not typically combined, researchers at Columbia University ... bone and other tissues. , The inability to foster ... new blood vessels from pre-existing vessels has been ... included the use of angiogenic growth factors and the ...
Other Biology News:Tracking the molecular pathway to mixed-lineage leukemia 2Columbia University scientist devises new way to more rapidly generate bone tissue 2